Nothing
Bayesian models to estimate causal effects of biological treatments on time-to-event endpoints in clinical trials with principal strata defined by the occurrence of antidrug antibodies. The methodology is based on Frangakis and Rubin (2002) <doi:10.1111/j.0006-341x.2002.00021.x> and Imbens and Rubin (1997) <doi:10.1214/aos/1034276631>, and here adapted to a specific time-to-event setting.
Package details |
|
---|---|
Author | Christian Stock [aut, cre] (<https://orcid.org/0000-0002-3493-3234>), Emma Torrini [aut], Boehringer Ingelheim Pharma GmbH & Co. KG [cph, fnd] |
Maintainer | Christian Stock <christian.stock@boehringer-ingelheim.com> |
License | GPL (>= 3) |
Version | 0.0.7 |
URL | https://github.com/Boehringer-Ingelheim/BPrinStratTTE https://boehringer-ingelheim.github.io/BPrinStratTTE/ |
Package repository | View on CRAN |
Installation |
Install the latest version of this package by entering the following in R:
|
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.